While CD40 agonism broadly activates a variety of hematopoietic cell types that include B cells and macrophages, its activation of DCs, in particular cDC1s, plays an essential role in tumor immunity as illustrated by abrogation of tumor control in murine Batf3-/- models (162, 165). This evidence concerns the gene CD40 and neoplasm.